INHIBRX BIOSCIENCES: CURRENTLY CONDUCTING PHASE 1/2 STUDY OF INBRX-106 IN PERIOPERATIVE SETTING OF NSCLC, WITH INITIAL RESULTS TARGETED BY MID-2027

Reuters · 1d ago

Please log in to view news